Chair, Computational Biology Program, Sloan-Kettering Institute
Current areas of research in the Sander group include identification of oncogenically altered pathways from genomic and molecular profiling in cancer, algorithms for the analysis of cancer genomics data, design of combinatorial cancer therapy, drug target identification, knowledge representation of biological pathways, protein evolution, specificity in protein networks, and the function of small RNAs.
In the role of Faculty Member, Chris Sander contributes recommendations and reviews to the Structural Genomics Section in the Structural Biology Faculty, writing brief accessible comments to summarize the value of the articles and adding rating score.
The Faculty comprises Heads of Faculty, Heads of Section, Faculty Members and Associate Faculty Members, as well as an International Advisory Board.
Read more about F1000Prime »